CD274 and melanoma: As demonstrated in this research, the use of [99mTc]Tc-iPD-L1/SPECT in the patient with plantar malignant melanoma allowed the differentiation between lesions that express PD-L1 protein and those that do not, helping to determine whether or not immunotherapy is a good option for the patient’s treatment.